Fda approves labeling update for abbott's heartmate 3 heart pump for use in pediatric patients

Abbott park, ill., dec. 17, 2020 /prnewswire/ -- abbott (nyse: abt) today announced the u.s. food and drug administration (fda) has approved updated labeling for the company's heartmate 3™ heart pump to be used in pediatric patients with advanced refractory left ventricular heart failure....
ABT Ratings Summary
ABT Quant Ranking